(HealthDay)—Tecentriq (atezolizumab) has been approved by the U.S. Food and Drug Administration to treat adults with extensive-stage small cell lung cancer (ES-SCLC).
Mar 19, 2019
0
0
Researchers at the Stanford University School of Medicine have demonstrated a method of forecasting which breast cancer patients will suffer heart problems from a commonly used chemotherapy drug.
Mar 14, 2019
0
40
Ovarian cancer is not the most common form of cancer, but it's among the deadliest. That's because about 70 percent of cases recur. A new study by researchers at the University of Pittsburgh, UPMC Hillman Cancer Center, Magee-Womens ...
Mar 12, 2019
0
605
Shortages of essential chemotherapy drugs for children undergoing cancer treatment has been an increasingly frequent obstacle for patients and hospitals across the country. In a new position paper in JAMA Pediatrics, Baylor ...
Mar 5, 2019
0
0
Chemotherapy drugs are lifesaving to cancer patients, but these toxic drugs are hazardous to the health care workers who come into contact with them. Despite the risks, many health care workers do not use recommended personal ...
Mar 1, 2019
0
3
In long-term survivors of childhood cancer, cardiovascular disease is a leading cause of early death from non-cancer causes. In a new study, published Jan. 31 in JAMA Oncology, researchers compared four chemotherapy drugs ...
Jan 31, 2019
0
4
More than half of cancer survivors suffer from cognitive impairment from chemotherapy that lingers for months or years after the cancer is gone. In a new study explaining the cellular mechanisms behind this condition, scientists ...
Dec 6, 2018
0
2070
The selection of a first-line chemotherapy drug to treat many types of cancer is often a clear-cut decision governed by standard-of-care protocols, but what drug should be used next if the first one fails?
Nov 7, 2018
0
90
Researchers in Brazil have discovered a new effect of a drug widely used as a chemotherapeutic agent and offered to patients free of charge by SUS, the national health service.
Oct 25, 2018
0
2
The hair loss, fatigue and nausea were a given. As a nurse, Toni C. Wild had seen patients faced with these common side effects of chemotherapy. What Wild did not expect when she was diagnosed with breast cancer at age 29 ...
Oct 16, 2018
0
5
